Preferred | Not Preferred | ||||||
---|---|---|---|---|---|---|---|
Topic | Class | n | % | n | % | pwithoutBonferroni | pwithBonferroni |
What is it? | 1 | 14 | 12.80 | 95 | 87.20 | 1.000 | 6.000 |
2 | 5 | 3.80 | 127 | 96.20 | 0.003* | 0.020* | |
3 | 30 | 21.30 | 111 | 78.70 | 0.007* | 0.039* | |
4 | 15 | 13.30 | 98 | 86.70 | 0.100 | 5.998 | |
Who is in the at-risk group? | 1 | 12 | 11.00 | 97 | 89.00 | 0.696 | 4.177 |
2 | 11 | 8.30 | 121 | 91.70 | 0.124 | 0.743 | |
3 | 36 | 25.50 | 105 | 74.50 | 0.0004* | 0.002* | |
4 | 14 | 12.40 | 99 | 87.60 | 0.887 | 5.323 | |
How is its progression? | 1 | 2 | 1.80 | 107 | 98.20 | 0.022* | 0.133 |
2 | 8 | 6.10 | 124 | 93.90 | 0.465 | 2.787 | |
3 | 25 | 17.70 | 116 | 82.30 | 0.002* | 0.014* | |
4 | 13 | 11.50 | 100 | 88.50 | 0.921 | 5.527 | |
Is there any treatment? What are the methods of treatment? (Drugs, vaccines, physiotherapy, etc.) | 1 | 19 | 17.40 | 190 | 82.60 | 0.696 | 4.177 |
2 | 21 | 15.90 | 111 | 84.10 | 0.307 | 1.841 | |
3 | 29 | 20.60 | 112 | 79.40 | 0.984 | 5.903 | |
4 | 38 | 33.60 | 75 | 66.40 | 0.007* | 0.039* |